Berkshire Hathaway Stock Rose 10 Days in a Row in October for the First Time Since 2018. Here's What History Says Comes Next.

Berkshire Hathaway Class B shares recorded 10 consecutive higher closes from Oct. 1 through Oct. 14, rising from about $498 to $526, and later topped $547—above the May 2025 record close of $539.89. In four of six prior instances since 1998, the stock was higher 12 months later, though the small sample does not predict future returns. Under CEO Greg Abel, Berkshire doubled down on Alphabet, added to Delta Air Lines and repurchased about $4.4 billion of shares; the article is bullish on its long-term fundamentals while cautioning that a record price may affect investment attractiveness.

Analysis

The useful signal is capital allocation, not the 10-session streak. Berkshire’s repurchases can provide a conditional bid in a selloff, but they are not a price floor: management’s willingness to buy depends on its estimate of intrinsic value, and the reported $4.4B is not interpretable without the period, shares retired, and comparison with Berkshire’s equity value. At a record, repurchases may pause precisely when investors most want confirmation. Likewise, the Alphabet and Delta additions are not enough to infer a material change in Berkshire’s earnings or NAV without position sizes.

The defensive case is real but not uniform. Insurance can face catastrophe and reserve volatility; rail and industrial results are exposed to economic activity; utilities bring regulation and capital-spending demands. A downturn therefore could weaken operating results even as Berkshire’s cash flexibility supports relative resilience. The historical down-market record is a small, backward-looking sample, not a hedge ratio. Over 1–3 months, the key checks are the pace of repurchases and operating earnings; over 6–18 months, Abel’s deployment discipline and operating performance matter more than the leadership transition narrative. The contrarian risk is paying a premium for perceived safety after a sharp advance without valuation evidence. The streak alone offers no edge.

Key Decisions for Investors

• Do not chase Berkshire solely on the winning streak or treat the buyback as downside protection. For a long-horizon allocation, scale in on weakness rather than making a full tactical entry at a record; verify repurchase timing, dollar pace, and shares retired before assigning it meaningful per-share support.
• For a defensive relative-value sleeve, consider a modest long Berkshire / short broad-market exposure only if the objective is to reduce equity beta—not as a claim that Berkshire must outperform. Reassess if Berkshire’s operating earnings weaken or it fails to show relative resilience in a market drawdown.
• Monitor the next disclosures for Berkshire operating earnings, insurance results, and buyback activity. A sustained buyback pause alongside weakening operating results would challenge the resilience thesis; continued repurchases at lower prices and stable operations would support it.
• Do not trade GOOG or DAL on these portfolio additions alone. Position sizes and transaction economics are missing, so their impact on Berkshire’s value—and any incremental demand for either stock—cannot be established from this information.